Case Study 2010: N-Pharma – Quiz #3
Recommend on Google+
Here’s the third quiz for students to test their comprehension of the N-Pharma case study. Give yourself 5 mins, i.e. 30 seconds per question…
N-Pharma – Quiz #3
1. Why did N-Pharma create the post of ‘Director of Corporate Social Responsibility’?
2. Who is Suzuko Tanaka?
3. Which of N-Pharma’s subsidiaries recently faced a liquidity problem?
4. Who are Anigam?
5. For strategic option 2, where is N-Pharma considering setting up a major centre?
6. What is the name of N-Pharma’s painkiller, with around 33% market share in Japan and the USA?
7. Does N-Pharma currently sell some of its drugs in China?
8. What is N-Pharma’s key strength in launching new drugs?
9. Do the employees in Canada or Australia have a problem with long chains of command?
10. Is Anigam well established in Asia?
Answers
1. Negative publicity in 2008 re: testing drugs on animals
2. Japanese financial auditor
3. USA
4. Specialist in animal drugs; diversification option for N-Pharma to merge with Anigam
5. Beijing/China
6. Pharmax
7. Yes
8. Well-established brand name
9. Canada
10. No – only in USA and Europe
Other activities to help prepare for the Paper 1 N-Pharma case study:
N-Pharma – Top 10 activities to prepare for the case study
Preparing for the pre-seen case study: N-Pharma
Case Study 2010:
N-Pharma – Quiz #2
Case Study 2010: N-Pharma – Quiz #1
blog comments powered by Disqus
TEACHER RESOURCE NEWSLETTER FOR IB DIPLOMA - ADD YOUR DETAILS
